Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02481219 · ClinicalTrials.gov registry record · NA
Optimization of the Bowel Preparation Regimen for the PillCam® COLON 2 Capsule Endoscopy Procedure
A NA study, sponsored by Medtronic - MITG.
- Completed
- Registry status
- NA
- Development phase
- 122
- Enrollment target
NCT02481219 is a NA study that has completed, run by Medtronic - MITG. The registered enrollment target is 122 participants.
The verdict
NCT02481219, a NA study, has completed, sponsored by Medtronic - MITG.
- COMPLETED
- Registry status
- NA
- Development phase
- 122 participants
- Enrollment target
Study Summary
This study is designed to determine the optimal bowel preparation regimen for PillCam® COLON 2 Capsule Endoscopy System (CCE) procedures in average risk patients. Patients will be randomized to receive one of two bowel preparation regimens prior to PillCam CCE.
Interventions
- DRUG Erythromycin
- DRUG Metoclopramide
- DRUG PEG
- DEVICE PillCam® COLON 2 procedure-CONTROL
- DRUG Senna tablets
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 122 participants |
| Start Date | 2015-05 |
| Est. Completion | 2016-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02481219
The ClinicalTrials.gov registry entry for NCT02481219 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 122 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic - MITG, which has 119 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Erythromycin is the first listed.
NCT02481219 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02481219 about?
NCT02481219 is a clinical study titled "Optimization of the Bowel Preparation Regimen for the PillCam® COLON 2 Capsule Endoscopy Procedure". This study is designed to determine the optimal bowel preparation regimen for PillCam® COLON 2 Capsule Endoscopy System (CCE) procedures in average risk patients. Patients will be randomized to receive one of two bowel preparation regimens prior to PillCam CCE.
What is the current status of trial NCT02481219?
This trial is currently completed. It is a NA study. The enrollment target is 122 participants. The study started on 2015-05. Estimated completion is 2016-02.
What interventions are being tested in trial NCT02481219?
The interventions under investigation include: Erythromycin (DRUG), Metoclopramide (DRUG), PEG (DRUG), PillCam® COLON 2 procedure-CONTROL (DEVICE), Senna tablets (DRUG).
Who is sponsoring clinical trial NCT02481219?
This trial is sponsored by Medtronic - MITG, which has 119 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.